BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19146394)

  • 1. A dual-mode fluorescence strategy for screening HAT modulators.
    Xie N; Elangwe EN; Asher S; Zheng YG
    Bioconjug Chem; 2009 Feb; 20(2):360-6. PubMed ID: 19146394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent reporters of the histone acetyltransferase.
    Wu J; Zheng YG
    Anal Biochem; 2008 Sep; 380(1):106-10. PubMed ID: 18558077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetyl transferases as emerging drug targets.
    Dekker FJ; Haisma HJ
    Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
    Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
    Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
    Sagar V; Zheng W; Thompson PR; Cole PA
    Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel design method of ratiometric fluorescent probes based on fluorescence resonance energy transfer switching by spectral overlap integral.
    Takakusa H; Kikuchi K; Urano Y; Kojima H; Nagano T
    Chemistry; 2003 Apr; 9(7):1479-85. PubMed ID: 12658644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
    Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.
    Riester D; Hildmann C; Haus P; Galetovic A; Schober A; Schwienhorst A; Meyer-Almes FJ
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3651-6. PubMed ID: 19457659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication.
    Mantelingu K; Reddy BA; Swaminathan V; Kishore AH; Siddappa NB; Kumar GV; Nagashankar G; Natesh N; Roy S; Sadhale PP; Ranga U; Narayana C; Kundu TK
    Chem Biol; 2007 Jun; 14(6):645-57. PubMed ID: 17584612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer.
    Riester D; Hildmann C; Schwienhorst A; Meyer-Almes FJ
    Anal Biochem; 2007 Mar; 362(1):136-41. PubMed ID: 17250798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules.
    Arif M; Pradhan SK; Thanuja GR; Vedamurthy BM; Agrawal S; Dasgupta D; Kundu TK
    J Med Chem; 2009 Jan; 52(2):267-77. PubMed ID: 19086895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-step fluorescence resonance energy transfer-based quenching assay for screening of caspase-3 inhibitors.
    Valanne A; Malmi P; Appelblom H; Niemelä P; Soukka T
    Anal Biochem; 2008 Apr; 375(1):71-81. PubMed ID: 18211811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
    Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
    Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
    Arif M; Kumar GV; Narayana C; Kundu TK
    J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
    Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
    Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.
    Liu X; Wang L; Zhao K; Thompson PR; Hwang Y; Marmorstein R; Cole PA
    Nature; 2008 Feb; 451(7180):846-50. PubMed ID: 18273021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition.
    Dancy BM; Crump NT; Peterson DJ; Mukherjee C; Bowers EM; Ahn YH; Yoshida M; Zhang J; Mahadevan LC; Meyers DJ; Boeke JD; Cole PA
    Chembiochem; 2012 Sep; 13(14):2113-21. PubMed ID: 22961914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones.
    Dekker FJ; Ghizzoni M; van der Meer N; Wisastra R; Haisma HJ
    Bioorg Med Chem; 2009 Jan; 17(2):460-6. PubMed ID: 19111471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
    van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
    Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.